Generic

Federal Judge Upholds Ban on Generic Versions of Lilly’s Breakthrough Weight Loss Medication

by

Indianapolis — A federal judge in Indiana has refused to issue an injunction that would have halted a ban on unauthorized copies of a widely popular weight-loss medication produced by Eli Lilly and Company. This decision keeps in place the enforcement against the manufacturing and distribution of generic versions of the pharmaceutical giant’s patented drug. This ruling directly impacts a number of pharmaceutical manufacturers who have been accused by Eli Lilly of infringing on its patents by replicating Mounjaro, a drug which has shown significant efficacy in both weight management and the treatment of type … Read more

West Virginia Clinches $17 Million Settlement from Pfizer and Ranbaxy Over Generic Drug Market Delay

by

CHARLESTON, W.Va. — State authorities in West Virginia have concluded a significant legal dispute with pharmaceutical giants Pfizer and Ranbaxy, accusing them of anti-competitive practices that delayed the release of a generic cholesterol medication. Announced on Thursday, this resolution resulted from allegations that the drug manufacturers conspired to keep a cheaper, generic version of the popular drug Lipitor off the market for more than eighteen months. At the core of the issue was the patent for Lipitor, which expired in 2010. However, it wasn’t until the lawsuit, filed in 2013, that the details surrounding the … Read more